Silvec Announces EPA Registration for its Novel Therapy Delivery Technology

Silvec Receives EPA Registration for Innovative Therapy Delivery Technology

Silvec Announces EPA Registration for its Novel Therapy Delivery Technology Silvec Biologics Inc., a Maryland-based agricultural biotechnology company, is pleased to announce that its novel RNA-based therapy delivery product is now registered for unconditional commercial use under the U.S. Environmental…

Read MoreSilvec Receives EPA Registration for Innovative Therapy Delivery Technology
Almirall

Almirall Partners With CrystalO to Develop Novel Small Molecules for Medical Dermatology

Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology Almirall, S.A. (ALM), a global biopharmaceutical company dedicated to medical dermatology based in Barcelona, announced a collaboration and licensing agreement with Shenzhen CrystalO…

Read MoreAlmirall Partners With CrystalO to Develop Novel Small Molecules for Medical Dermatology
Bruker

Bruker Invests in MIMETAS to Accelerate Human-Relevant Drug Discovery Technologies

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development Bruker Corporation announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The…

Read MoreBruker Invests in MIMETAS to Accelerate Human-Relevant Drug Discovery Technologies
Greenstone Biosciences Receives

Greenstone Biosciences Secures NIH Grant to Develop Cardiac Fibrosis Therapy for Duchenne Muscular Dystrophy

Greenstone Biosciences Receives NIH R61 Grant to Advance Cardiac Fibrosis Therapeutics for Duchenne Muscular Dystrophy Greenstone Biosciences, a biotechnology company advancing New Approach Methodologies (NAMs) for drug discovery, announced that it has received a Catalyze R61 award from the National…

Read MoreGreenstone Biosciences Secures NIH Grant to Develop Cardiac Fibrosis Therapy for Duchenne Muscular Dystrophy
Study Shows

Study Shows equicenta® CTM Allograft Accelerates Performance Horse Recovery

New Multi-Center Study Shows equicenta® CTM, Ready-to-Use, Equine Umbilical Cord Allograft Outperforms Standard of Care in Returning Performance Horses to Work Equine Performance Labs (EPL), the team behind equicenta® CTM — announced the publication of a peer-reviewed, prospective, controlled clinical…

Read MoreStudy Shows equicenta® CTM Allograft Accelerates Performance Horse Recovery
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1

FDA Approves Takeda’s ORZEYFUL™ (oveporexton), First Treatment Targeting the Root Cause of Narcolepsy Type 1

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 Takeda announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the…

Read MoreFDA Approves Takeda’s ORZEYFUL™ (oveporexton), First Treatment Targeting the Root Cause of Narcolepsy Type 1
Mirum Pharmaceuticals Announces Q2 2026 Financial Results and Key Business Updates

Mirum Pharmaceuticals Announces Q2 2026 Financial Results and Key Business Updates

Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update Mirum Pharmaceuticals, Inc. a leading rare disease company, reported financial results for the second quarter 2026 and provided a business update. Mirum delivered another strong quarter, with continued…

Read MoreMirum Pharmaceuticals Announces Q2 2026 Financial Results and Key Business Updates
Propel Software Introduces Manufacturing Hub for Seamless Integration Across 12 ERP Systems

Propel Software Introduces Manufacturing Hub for Seamless Integration Across 12 ERP Systems

Propel Software Launches Manufacturing Hub Providing Seamless and Standardized Integration with 12 ERP Platforms Propel, creator of the first product value management (PVM) platform to transform how manufacturers develop, launch, and service products, today announced its Summer 2026 release highlighted…

Read MorePropel Software Introduces Manufacturing Hub for Seamless Integration Across 12 ERP Systems
DXP Enterprises Acquires Mequipco Ltd. to Expand Industrial Solutions Portfolio

DXP Enterprises Acquires Mequipco Ltd. to Expand Industrial Solutions Portfolio

DXP Enterprises, Inc. Announces Acquisition of Mequipco Ltd. DXP Enterprises, Inc. announced that it has completed the acquisition of Mequipco Ltd. Founded in 1974, Mequipco is headquartered in Calgary, Alberta Canada and operates out of three locations servicing Western Canada including…

Read MoreDXP Enterprises Acquires Mequipco Ltd. to Expand Industrial Solutions Portfolio